Page last updated: 2024-08-25

zoledronic acid and Carcinoma

zoledronic acid has been researched along with Carcinoma in 32 studies

Research

Studies (32)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	10 (31.25)	29.6817
2010's	21 (65.63)	24.3611
2020's	1 (3.13)	2.80

Authors

Authors	Studies
Gao, Q; Guo, J; You, H; Zhao, Y; Zhu, H	1
Fukuoka, M; Hasegawa, Y; Miyatake, N; Ota, T; Tanaka, N; Tokunaga, M; Tsukuda, H	1
Gerngroß, C; Hahnefeld, L; Hohlweg-Majert, B; Jansen, H; Kehl, V; Koerdt, S; Otto, S; Pautke, C; Ristow, O; Schwaiger, M	1
Charehbili, A; Kroep, JR; Liefers, GJ; Meershoek-Klein Kranenbarg, WM; Nortier, JW; Putter, H; Smit, VT; van de Velde, CJ; van Leeuwen-Stok, AE; Wasser, MN	1
Manabe, J; Miyata, S; Orita, Y; Sugitani, I; Takao, S; Toda, K	1
Bertaglia, V; Buttigliero, C; Di Maio, M; Scagliotti, GV; Tucci, M; Vignani, F	1
Amadori, D; Brigliadori, G; Carloni, S; Fabbri, F; Silvestrini, R; Tesei, A; Ulivi, P; Vannini, I; Zoli, W	1
Berruti, A; Brizzi, MP; Dogliotti, L; Gorzegno, G; Porpiglia, F; Priola, AM; Ragni, F; Sculli, CM; Tampellini, M	1
Alameda Hernando, C; Díaz Guardiola, P; Guijarro de Armas, G; Iglesias Bolaños, P; Pavón de Paz, I; Vega Piñero, B	1
Allen, MJ; Arrington, SA; Fisher, ER; Mann, KA; Willick, GE	1
Aapro, M; Coleman, R; Gnant, M; Hadji, P; Lipton, A	1
Hollstein, S; Hölzle, F; Kriwalsky, MS; Kunkel, M; Maurer, P; Rashad, A; Sandulescu, T; Stricker, I	1
Deng, H; Eagleton, MC; Harding, JC; Hurchla, MA; Lairmore, MD; Niewiesk, S; Piwnica-Worms, D; Ratner, L; Rauch, DA; Rosol, TJ; Shea, LK; Weber, JD; Weilbaecher, KN	1
Chen, JY; Hong, CQ; Huang, WL; Li, WB; Li, XY; Lin, YC; You, YJ	1
Kakehi, Y; Kato, T; Kazuki, N; Kushida, Y; Kuwata, Y; Matsuoka, Y; Taoka, T; Yamamoto, N	1
Hirata, H; Kanamaru, H; Kato, K; Nagahama, K; Yagibashi, Y; Yamamoto, M	1
Argonza-Aviles, E; Beck, JT; Bosserman, L; Brufsky, AM; Ericson, SG; Harker, WG; Hohneker, J; Jin, L; Perez, EA; Seidler, C; Vogel, C; Warsi, G	1
Ashida, C; Higashida, A; Kawara, F; Kondo, T; Mamori, S; Okutani, T; Onishi, K; Takeda, A; Yamada, H	1
Chen, JY; Hong, CQ; Huang, WL; Li, XY; Lin, W; Lin, YC; Wang, HB	1
Huang, WL; Li, XY; Lin, SL; Lin, W; Lin, WZ; Lin, YC; Wang, HB	2
Arao, T; Mori, H; Okada, Y; Tanaka, Y; Torimoto, K	1
Barney, RB; Biskupiak, JE; Brandt, P; Gaffney, DK; Namjoshi, M; Nickman, NA; Young, J	1
Mukherjee, K; Saha, A; Sonthalia, N; Talukdar, A	1
Armstrong, AJ; Fizazi, K; Freedland, S; Pienta, K; Saad, F; Saylor, PJ; Smith, MR; Tombal, B	1
Chen, BL; Coleman, RE; Dugan, W; Eisenberg, PD; Gordon, DH; Kaminski, M; Major, P; Provencher, L; Rosen, LS; Seaman, J; Simeone, J	1
Curley, T; Delacruz, A; Diani, M; Fallon, M; Fleisher, M; Flombaum, C; Kelly, WK; Morris, MJ; Scher, HI; Schwartz, L; Slovin, S; Smaletz, O; Solit, D; Zhu, A	1
Bishop, PA; Hay, KD	1
Kenna, T; Mattarollo, SR; Nicol, AJ; Nieda, M	1
Engroff, SL; Kim, DD	1
Allen, MJ; Arrington, SA; Damron, TA; Mann, KA	1
Barnett, BL; Deprèle, S; Ebetino, FH; Evdokimov, A; Hogan, JM; Kashemirov, BA; McKenna, CE	1

Reviews

4 review(s) available for zoledronic acid and Carcinoma

Article	Year
Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer. Cancer treatment reviews, 2016, Volume: 44 Topics: Androstenes; Anilides; Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma; Dasatinib; Denosumab; Diphosphonates; Docetaxel; Humans; Imidazoles; Male; Mitoxantrone; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Pyridines; Radioisotopes; Radium; Taxoids; Zoledronic Acid	2016
Dosing of zoledronic acid throughout the treatment continuum in breast cancer. Critical reviews in oncology/hematology, 2011, Volume: 79, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Diphosphonates; Drug Administration Schedule; Drug Dosage Calculations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Imidazoles; Injections, Intravenous; Neoplasm Staging; Osteoporosis; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Treatment Outcome; Zoledronic Acid	2011
[A very elderly case of advanced gastric cancer with disseminated carcinomatosis of bone marrow and multiple bone metastasis, diagnosed by extremely elevated serum alkaline phosphatase levels, and treated with low-dose S-1 to avoid disseminated intravascu Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2011, Volume: 108, Issue:11 Topics: Aged, 80 and over; Alkaline Phosphatase; Antimetabolites, Antineoplastic; Bone Marrow Neoplasms; Bone Neoplasms; Carcinoma; Diphosphonates; Disseminated Intravascular Coagulation; Drug Combinations; Female; Humans; Imidazoles; Oxonic Acid; Stomach Neoplasms; Tegafur; Zoledronic Acid	2011
New and emerging therapies for bone metastases in genitourinary cancers. European urology, 2013, Volume: 63, Issue:2 Topics: Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma; Denosumab; Diphosphonates; Female; Humans; Imidazoles; Kidney Neoplasms; Male; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Randomized Controlled Trials as Topic; RANK Ligand; Urinary Bladder Neoplasms; Urogenital Neoplasms; Urothelium; Zoledronic Acid	2013

Trials

3 trial(s) available for zoledronic acid and Carcinoma

Article	Year
Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2014, Volume: 40, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cyclophosphamide; Diphosphonates; Docetaxel; Doxorubicin; Female; Humans; Imidazoles; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Receptor, ErbB-2; Receptors, Estrogen; ROC Curve; Taxoids; Treatment Outcome; Tumor Burden; Zoledronic Acid	2014
Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole. Cancer, 2012, Mar-01, Volume: 118, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Agents; Bone and Bones; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Letrozole; Middle Aged; Nitriles; Organ Size; Osteoporosis, Postmenopausal; Postmenopause; Triazoles; Zoledronic Acid	2012
Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion. Cancer, 2004, Jan-01, Volume: 100, Issue:1 Topics: Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma; Diphosphonates; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fractures, Bone; Humans; Imidazoles; Infusions, Intravenous; Middle Aged; Osteolysis; Pamidronate; Risk Factors; Spinal Cord Compression; Zoledronic Acid	2004

Other Studies

25 other study(ies) available for zoledronic acid and Carcinoma

Article	Year
TIGIT-expressing zoledronate-specific γδ T cells display enhanced antitumor activity. Journal of leukocyte biology, 2022, Volume: 112, Issue:6 Topics: Carcinoma; Carcinoma, Renal Cell; Cytokines; Humans; Kidney Neoplasms; Receptors, Antigen, T-Cell, gamma-delta; Receptors, Immunologic; Zoledronic Acid	2022
Use of hormone therapies in disseminated carcinomatosis of the bone marrow associated with hormone receptor-positive breast cancer. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, Volume: 34, Issue:4 Topics: Bone Marrow Neoplasms; Breast Neoplasms; Carcinoma; Diphosphonates; Disseminated Intravascular Coagulation; Female; Humans; Imidazoles; Middle Aged; Treatment Outcome; Zoledronic Acid	2018
Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates. The British journal of oral & maxillofacial surgery, 2014, Volume: 52, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Neoplasms; Bone Remodeling; Breast Neoplasms; Carcinoma; Denosumab; Diphosphonates; Female; Femur; Frontal Bone; Humans; Image Processing, Computer-Assisted; Imidazoles; Jaw Diseases; Mandible; Maxilla; Middle Aged; Osteonecrosis; Radionuclide Imaging; RANK Ligand; Retrospective Studies; Zoledronic Acid	2014
Prospective Evaluation of Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid Carcinoma. Annals of surgical oncology, 2015, Volume: 22, Issue:12 Topics: Adult; Aged; Alkaline Phosphatase; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Carcinoma; Collagen Type I; Diphosphonates; Disease Progression; Female; Humans; Imidazoles; Male; Middle Aged; Pain; Peptides; Prospective Studies; Response Evaluation Criteria in Solid Tumors; Spinal Cord Compression; Thyroid Neoplasms; Zoledronic Acid	2015
Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line. Journal of translational medicine, 2008, Aug-08, Volume: 6 Topics: Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma; Caspase 3; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Diphosphonates; Docetaxel; Drug Synergism; Enzyme Activation; Fluorescent Dyes; Humans; Imidazoles; In Situ Nick-End Labeling; Male; MAP Kinase Kinase 1; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Rhodamines; Taxoids; Time Factors; Zoledronic Acid	2008
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:2 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma; Diphosphonates; Drug Administration Schedule; Fatal Outcome; Female; Humans; Imidazoles; Radiography; Urinary Bladder Neoplasms; Zoledronic Acid	2009
[Primary hyperparathyroidism. An alternative to the surgery]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2009, Volume: 56, Issue:3 Topics: Adenoma; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Cinacalcet; Comorbidity; Contraindications; Diphosphonates; Drug Therapy, Combination; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Imidazoles; Kidney Function Tests; Kidney Neoplasms; Naphthalenes; Parathyroid Neoplasms; Parathyroidectomy; Treatment Refusal; Zoledronic Acid	2009
Anabolic and antiresorptive drugs improve trabecular microarchitecture and reduce fracture risk following radiation therapy. Calcified tissue international, 2010, Volume: 87, Issue:3 Topics: Anabolic Agents; Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Carcinoma; Diphosphonates; Drug Therapy, Combination; Female; Femoral Neoplasms; Imidazoles; Mice; Mice, Nude; Osteolysis; Parathyroid Hormone; Zoledronic Acid	2010
Bisphosphonate-related osteonecrosis of the maxilla and sinusitis maxillaris. International journal of oral and maxillofacial surgery, 2011, Volume: 40, Issue:3 Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bone Density Conservation Agents; Carcinoma; Chronic Disease; Debridement; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Injections, Intravenous; Male; Maxillary Diseases; Maxillary Sinusitis; Middle Aged; Osteonecrosis; Osteoporosis; Osteotomy; Recurrence; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid	2011
The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice. PloS one, 2010, Dec-30, Volume: 5, Issue:12 Topics: Animals; Bone Remodeling; Carcinoma; Diphosphonates; Gene Products, tax; Genes, p53; Heterozygote; Imidazoles; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Genetic; Osteoblasts; Osteoclasts; Tumor Suppressor Protein p14ARF; Tumor Suppressor Protein p53; Zoledronic Acid	2010
Zoledronic acid inhibits proliferation and impairs migration and invasion through downregulating VEGF and MMPs expression in human nasopharyngeal carcinoma cells. Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:2 Topics: Blotting, Western; Bone Density Conservation Agents; Carcinoma; Cell Adhesion; Cell Movement; Cell Proliferation; Diphosphonates; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Humans; Imidazoles; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Zoledronic Acid	2012
[Disseminated carcinomatosis of the bone marrow in two patients with prostate cancer]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2011, Volume: 102, Issue:1 Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Bone Marrow Neoplasms; Carcinoma; Diphosphonates; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Fatal Outcome; Humans; Imidazoles; Leuprolide; Male; Middle Aged; Nitriles; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome; Zoledronic Acid	2011
[A case of prostate cancer with disseminated carcinomatosis of bone marrow which responded to Zoledronic acid]. Hinyokika kiyo. Acta urologica Japonica, 2011, Volume: 57, Issue:6 Topics: Aged; Bone Density Conservation Agents; Bone Marrow Neoplasms; Carcinoma; Diphosphonates; Humans; Imidazoles; Male; Neoplasm Seeding; Prostatectomy; Prostatic Neoplasms; Zoledronic Acid	2011
[Inhibitory effects of zoledronic acid on cell proliferation and invasion in human nasopharyngeal carcinoma cell line HNE1]. Zhonghua yi xue za zhi, 2011, Aug-30, Volume: 91, Issue:32 Topics: Carcinoma; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Humans; Imidazoles; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Vascular Endothelial Growth Factor A; Zoledronic Acid	2011
Zoledronic acid inhibits human nasopharyngeal carcinoma cell proliferation by activating mitochondrial apoptotic pathway. Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Flow Cytometry; Gene Expression; Humans; Imidazoles; In Situ Nick-End Labeling; Mitochondria; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Zoledronic Acid	2012
[Study of sequence-dependent in vitro effects of zoledronic acid and paclitaxel upon human nasopharyngeal carcinoma cell line HNE1]. Zhonghua yi xue za zhi, 2012, Apr-24, Volume: 92, Issue:16 Topics: Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Humans; Imidazoles; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Zoledronic Acid	2012
A case of zoledronate-induced tubulointerstitial nephritis with Fanconi syndrome. Endocrine journal, 2012, Volume: 59, Issue:12 Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma; Diphosphonates; Fanconi Syndrome; Female; Humans; Imidazoles; Middle Aged; Nephritis, Interstitial; Zoledronic Acid	2012
Characterization of clinical course and usual care patterns in female metastatic breast cancer patients treated with zoledronic acid. Breast (Edinburgh, Scotland), 2013, Volume: 22, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cohort Studies; Diphosphonates; Disease Progression; Female; Fractures, Spontaneous; Humans; Imidazoles; Middle Aged; Musculoskeletal Pain; Palliative Care; Retrospective Studies; Treatment Outcome; Young Adult; Zoledronic Acid	2013
Treatment of hypertrophic osteoarthropathy in the case of pulmonary metastasis secondary-to-nasopharyngeal carcinoma with zoledronic acid: an enlightening experience. BMJ case reports, 2012, Nov-11, Volume: 2012 Topics: Adult; Bone Density Conservation Agents; Carcinoma; Diagnosis, Differential; Diphosphonates; Humans; Imidazoles; Infusions, Intravenous; Lung Neoplasms; Lymphatic Metastasis; Male; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Osteoarthropathy, Secondary Hypertrophic; Palliative Care; Tomography, X-Ray Computed; Zoledronic Acid	2012
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma. Cancer, 2004, May-01, Volume: 100, Issue:9 Topics: Aged; Aged, 80 and over; Calcitriol; Carcinoma; Cohort Studies; Dexamethasone; Diphosphonates; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Prostatic Neoplasms; Pulse Therapy, Drug; Risk Assessment; Survival Analysis; Treatment Outcome; Zoledronic Acid	2004
Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications. The New Zealand dental journal, 2006, Volume: 102, Issue:1 Topics: Adenocarcinoma; Aged, 80 and over; Bone Density Conservation Agents; Carcinoma; Diabetes Mellitus, Type 2; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Patient Care Planning; Tooth Extraction; Zoledronic Acid	2006
Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity. Cancer immunology, immunotherapy : CII, 2007, Volume: 56, Issue:8 Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Burkitt Lymphoma; Carcinoma; Cell Line, Tumor; Cisplatin; Colorectal Neoplasms; Concanavalin A; Cytotoxicity, Immunologic; Diphosphonates; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Genes, T-Cell Receptor delta; Genes, T-Cell Receptor gamma; Humans; Imidazoles; Interferon-gamma; Lovastatin; Lung Neoplasms; Male; Membrane Glycoproteins; Neoplasms; Perforin; Pore Forming Cytotoxic Proteins; Prostatic Neoplasms; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Urinary Bladder Neoplasms; Vincristine; Zoledronic Acid	2007
Treating bisphosphonate osteonecrosis of the jaws: is there a role for resection and vascularized reconstruction? Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2007, Volume: 65, Issue:11 Topics: Bone Density Conservation Agents; Bone Plates; Bone Transplantation; Breast Neoplasms; Carcinoma; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Mandibular Diseases; Middle Aged; Osteonecrosis; Pamidronate; Plastic Surgery Procedures; Surgical Flaps; Zoledronic Acid	2007
Concurrent administration of zoledronic acid and irradiation leads to improved bone density, biomechanical strength, and microarchitecture in a mouse model of tumor-induced osteolysis. Journal of surgical oncology, 2008, Mar-01, Volume: 97, Issue:3 Topics: Animals; Bone Density; Bone Density Conservation Agents; Carcinoma; Chemotherapy, Adjuvant; Diphosphonates; Disease Models, Animal; Female; Femoral Neoplasms; Imidazoles; Mice; Osteolysis; Tensile Strength; Tumor Burden; Zoledronic Acid	2008
Farnesyl pyrophosphate synthase enantiospecificity with a chiral risedronate analog, [6,7-dihydro-5H-cyclopenta[c]pyridin-7-yl(hydroxy)methylene]bis(phosphonic acid) (NE-10501): Synthetic, structural, and modeling studies. Bioorganic & medicinal chemistry letters, 2008, May-01, Volume: 18, Issue:9 Topics: Algorithms; Binding Sites; Bone Density Conservation Agents; Carcinoma; Computer Simulation; Crystallography, X-Ray; Diphosphonates; Enzyme Inhibitors; Etidronic Acid; Farnesyltranstransferase; Humans; Imidazoles; Inhibitory Concentration 50; Magnesium; Models, Chemical; Organophosphonates; Pyridines; Risedronic Acid; Stereoisomerism; Structure-Activity Relationship; Zoledronic Acid	2008